Fusion prostate biopsy is a new and revolutionary method to diagnose prostate cancer. It combines magnetic resonance imaging (MRI) scans with ultrasound (sound wave) technology to better detect and target abnormal areas in the prostate.
MRI scans are performed before the biopsy to provide detailed images of the prostate that ultrasound cannot see. During his biopsy, the patient’s MRI scans are fused or “laid over” the ultrasound images and serve as a roadmap of the patient’s prostate.
Fusion prostate biopsy is especially useful in finding hidden prostate cancers in men with rising or persistently high PSA levels, and a prior negative biopsy.
Compared to a traditional ultrasound biopsy of the prostate, a fusion prostate biopsy is:
- More accurate
- Can find hidden tumors that ultrasound cannot detect
- May reduce the number of tissue samples needed